BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 34684035)

  • 1. Chronic and Recurrent Herpes Zoster Ophthalmicus.
    Lee SM; Han J; Yang CM; Choi CY; Khoramnia R; Chung TY; Lim DH
    Medicina (Kaunas); 2021 Sep; 57(10):. PubMed ID: 34684035
    [No Abstract]   [Full Text] [Related]  

  • 2. Epidemiology of Herpes Zoster Ophthalmicus: Recurrence and Chronicity.
    Tran KD; Falcone MM; Choi DS; Goldhardt R; Karp CL; Davis JL; Galor A
    Ophthalmology; 2016 Jul; 123(7):1469-75. PubMed ID: 27067924
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of Ocular Manifestations and Visual Outcomes in Patients With Herpes Zoster Ophthalmicus.
    Szeto SK; Chan TC; Wong RL; Ng AL; Li EY; Jhanji V
    Cornea; 2017 Mar; 36(3):338-342. PubMed ID: 27741018
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinical presentations of Herpes Zoster Ophthalmicus (diagnosis and therapy)].
    Chernakova GM; Kleshcheva EA; Semenova TB
    Vestn Oftalmol; 2016; 132(5):75-80. PubMed ID: 27911430
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Herpes simplex and herpes zoster eye disease: presentation and management at a city hospital for the underserved in the United States.
    Edell AR; Cohen EJ
    Eye Contact Lens; 2013 Jul; 39(4):311-4. PubMed ID: 23771014
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Herpes zoster ophthalmicus: comparison of disease in patients 60 years and older versus younger than 60 years.
    Ghaznawi N; Virdi A; Dayan A; Hammersmith KM; Rapuano CJ; Laibson PR; Cohen EJ
    Ophthalmology; 2011 Nov; 118(11):2242-50. PubMed ID: 21788078
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Herpes Zoster Ophthalmicus Clinical Presentation and Risk Factors for Loss of Vision.
    Niederer RL; Meyer JJ; Liu K; Danesh-Meyer HV
    Am J Ophthalmol; 2021 Jun; 226():83-89. PubMed ID: 33571476
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Practice patterns and opinions in the management of recurrent or chronic herpes zoster ophthalmicus.
    Sy A; McLeod SD; Cohen EJ; Margolis TP; Mannis MJ; Lietman TM; Acharya NR
    Cornea; 2012 Jul; 31(7):786-90. PubMed ID: 22269677
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Herpes zoster ophthalmicus: acute keratitis.
    Li JY
    Curr Opin Ophthalmol; 2018 Jul; 29(4):328-333. PubMed ID: 29794881
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ocular complications and loss of vision due to herpes zoster ophthalmicus in patients with HIV infection and a comparison with HIV-negative patients.
    Nithyanandam S; Joseph M; Stephen J
    Int J STD AIDS; 2013 Feb; 24(2):106-9. PubMed ID: 23512510
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Late varicella-zoster virus dendriform keratitis in patients with histories of herpes zoster ophthalmicus.
    Hu AY; Strauss EC; Holland GN; Chan MF; Yu F; Margolis TP
    Am J Ophthalmol; 2010 Feb; 149(2):214-220.e3. PubMed ID: 19909942
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Current Practice Patterns and Opinions on the Management of Recent-Onset or Chronic Herpes Zoster Ophthalmicus of Zoster Eye Disease Study Investigators.
    Lo DM; Jeng BH; Gillespie C; Wu M; Cohen EJ
    Cornea; 2019 Jan; 38(1):13-17. PubMed ID: 30157049
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incidence of herpes zoster ophthalmicus: results from the Pacific Ocular Inflammation Study.
    Borkar DS; Tham VM; Esterberg E; Ray KJ; Vinoya AC; Parker JV; Uchida A; Acharya NR
    Ophthalmology; 2013 Mar; 120(3):451-456. PubMed ID: 23207173
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ocular surgery after herpes simplex and herpes zoster keratitis.
    Kanclerz P; Alio JL
    Int Ophthalmol; 2020 Dec; 40(12):3599-3612. PubMed ID: 32910331
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk of Herpes Zoster Ophthalmicus Recurrence After Recombinant Zoster Vaccination.
    Walia A; Sun Y; Acharya NR
    JAMA Ophthalmol; 2024 Mar; 142(3):249-256. PubMed ID: 38358762
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Herpes zoster ophthalmicus: frequency and risk factors for developing uncommon ocular manifestations.
    Dmitriev AA; Odden J; Mora-Boellstorff D; Kinchington PR; Sheridan K; Viehman JA; Price D; Koscumb S; Marroquin O; Sahel JA; Kowalski RP; Jhanji V; Errera MH
    Can J Ophthalmol; 2024 Jun; 59(3):201-207. PubMed ID: 37192736
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pediatric herpes zoster ophthalmicus: a systematic review.
    Hakim FE; Riaz K; Farooq A
    Graefes Arch Clin Exp Ophthalmol; 2023 Aug; 261(8):2169-2179. PubMed ID: 36949170
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence in the prevention of the recurrence of herpes simplex and herpes zoster keratitis after eye surgery.
    Gessa-Sorroche M; Kanclerz P; Alio J
    Arch Soc Esp Oftalmol (Engl Ed); 2022 Mar; 97(3):149-160. PubMed ID: 35248396
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effectiveness of the Recombinant Zoster Vaccine for Herpes Zoster Ophthalmicus in the United States.
    Lu A; Sun Y; Porco TC; Arnold BF; Acharya NR
    Ophthalmology; 2021 Dec; 128(12):1699-1707. PubMed ID: 33892049
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduction of the ocular complications of herpes zoster ophthalmicus by oral acyclovir.
    Cobo M
    Am J Med; 1988 Aug; 85(2A):90-3. PubMed ID: 3044100
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.